fashion -WSS

fashion

author：hotspot 2025-10-01 02:16:06 - browse：57985

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 5 dead in mass shooting on Caribbean island of St. Vincent: Police

entertainment

WSS

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Just how powerful is the placebo effect?

Just how powerful is the placebo effect?

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

US jobless claims fall again as labor market continues to flash strength

Hormonal contraceptives don’t actually treat endometriosis

focus

fashion

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

In rare move, senator releases unverified FBI source report alleging Biden bribe

How to save PrEP access — and even expand it

The Sacklers, horror, and ‘The Fall of the House of Usher’

ChatGPT in medicine: STAT answers readers' burning questions

'CMA Fest' 2023: How to watch, who is performing and more

State Dept. review finds Biden bears some blame for Afghanistan failures

HPV cancer vaccine study demonstrates efficacy

What does generative AI mean for health care? We asked experts

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

focus

Abortion clinic in Cancun will cater to Americans

More doctors should go into startup world

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Stanford president’s abrupt resignation sparks debate

The new shift in health care is toward less care

leisure time

focus

entertainment

hotspot